At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 31, 2026 at 20:00 ET
ResMed insiders sold $1.8M in shares over a 7-day period, led by CEO Michael Farrell's $1.13M open-market sale following the exercise of derivative securities. The total value represents 0.005% of ResMed's $33.6B market cap, indicating routine, non-material activity.
- CEO Michael Farrell sold 4,991 shares for $1.13M in an open-market transaction on 2026-04-07.
- Farrell also exercised derivative securities totaling 9,982 shares (one tranche at $0, one at $146.34), a non-cash event.
- Director Peter Farrell sold $450K and CFO Brett Sandercock sold $224K, both on 2026-04-01.
- Total insider selling: $1.8M over 7 days, all by insiders with pre-arranged 10b5-1 plans likely.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access